Statera BioPharma Inc
0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Statera BioPharma Inc STAB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.0911 19:00:00
Open Price Low Price High Price Close Price Prev Close
0.0911 0.0911
more quote information »

Recent News

Date Time Source Heading
1/31/20237:30IHNWFeaturedAmerican Green (OTC:ERBB) Quarterly Cannabis Cultivation Revenue Increased 69% over the same period last year.
11/18/202208:04EDGARProxy Statement - Notice of Shareholders Meeting..
11/15/202206:34EDGARCurrent Report Filing (8-k)
11/14/202217:53EDGARQuarterly Report (10-q)
10/27/202217:01EDGARCurrent Report Filing (8-k)
10/21/202209:02EDGARQuarterly Report (10-q)
10/17/202217:31EDGARCurrent Report Filing (8-k)
10/06/202206:01EDGARAnnual Report (10-k)
9/23/202206:02EDGARAmended Current Report Filing (8-k/a)
9/09/202206:01EDGARCurrent Report Filing (8-k)
8/26/202207:49GLOBENasdaq Resumes Trading in Statera Biopharma, Inc.
8/25/202211:48GLOBENasdaq Halts Statera Biopharma, Inc.
8/03/202215:00EDGARCurrent Report Filing (8-k)
6/14/202207:30GLOBEStatera Biopharma Announces BF Borgers CPA PC as Independent..
6/06/202216:53EDGARCurrent Report Filing (8-k)
5/27/202217:55EDGARCurrent Report Filing (8-k)
5/23/202216:05GLOBEStatera Biopharma Receives Notification Letter from Nasdaq..
5/13/202207:30GLOBEStatera Biopharma and Lay Sciences Inc. Announce Intent to..
4/27/202216:10GLOBEStatera Biopharma and Immune Therapeutics Inc. Announce..
4/22/202217:26GLOBEStatera Biopharma Receives Notification Letter from Nasdaq..
4/18/202216:56EDGARCurrent Report Filing (8-k)
4/15/202217:15EDGARCurrent Report Filing (8-k)
4/13/202216:05GLOBEStatera Biopharma and Coeptis Therapeutics Announce..
4/13/202209:23EDGARAmended Current Report Filing (8-k/a)
4/13/202207:00PRNUSCoeptis Therapeutics Announces Intent to Acquire TLR5..
3/31/202217:13EDGARCurrent Report Filing (8-k)
3/31/202216:05GLOBEStatera Biopharma, Inc. Files Form 12b-25
3/28/202207:30GLOBEStatera Biopharma, Inc. to Report Fourth Quarter and Full..
3/25/202216:08EDGARCurrent Report Filing (8-k)
3/25/202206:02EDGARCurrent Report Filing (8-k)
3/24/202217:28GLOBEStatera Biopharma Announces Closing of $5.7 Million..
3/22/202209:43SEEKStatera Biopharma slips on pricing ~$5.7M stock offering
3/22/202209:29GLOBEStatera Biopharma Announces Pricing of $5.7..
3/22/202209:21EDGARCurrent Report Filing (8-k)
3/22/202207:38GLOBECORRECTION -- Statera Biopharma Announces Proposed..
3/22/202207:34EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/21/202219:27EDGARInitial Statement of Beneficial Ownership (3)
3/21/202216:58SEEKStatera slides 18% as biopharma proposes stock offering
3/21/202216:50GLOBEStatera Biopharma Announces Proposed Underwritten Public..
3/08/202216:15GLOBEStatera Biopharma Announces Revised Preliminary Revenue and..
3/07/202214:09SEEKStatera advances research based on STAT-200 platform aimed..
3/07/202207:30GLOBEStatera Biopharma Advances Next-Gen Proprietary Compositions..
3/02/202209:08GLOBECORRECTION - Statera Biopharma Submits Phase 1 Clinical..
3/02/202207:30GLOBEStatera Biopharma Submits Phase 1 Clinical Trial Protocol to..
2/25/202217:32EDGARCurrent Report Filing (8-k)
2/25/202207:32GLOBEStatera Biopharma Announces Changes to Board of Directors
2/22/202209:14EDGARCurrent Report Filing (8-k)
2/22/202208:11SEEKStatera Biopharma reports prelim 2021 revenue of $1.49M
2/22/202207:51GLOBEStatera Biopharma Announces Preliminary Revenue and..
2/15/202209:04GLOBEStatera Biopharma, Inc., Announces Central Institutional..
2/15/202206:46EDGARAmended Statement of Ownership (sc 13g/a)